Information Library

Results for: Case Studies - Market Access

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Malaria Prevention in Sub-Saharan Africa

    June 24, 2011
    This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands

  • Advancing Vaccine Development in Australia and New Zealand

    April 11, 2011
    Quintiles rose to the challenge of a very aggressive vaccine recruitment timeline during the holiday period - and recruited 3,000+ subjects from 18-90 years of age within just 17 days - 25 days ahead of schedule.

  • Improved Commercialization Strategy through Stakeholder Network Mapping

    February 7, 2011
    Understanding the KOL and physicians influencer landscape is a mission critical component of a bio-pharma product’s market access strategy and commercialization plan. Influencer network mapping

  • Understanding Physician Preferences and Attitudes

    February 7, 2011
    This collection of case studies demonstrates how Market intelligence is used to gain a comprehensive understanding of physician preference and prescribing attitudes for RA drugs.

  • Vital Insights

    June 8, 2010
    Quintiles conducted an exhaustive analysis into global and U.S. responses to the use of comparative effectiveness research, identifying key signals to help the customer recognize risk scenarios.

  • Bridging Cultures

    May 9, 2010
    Takeda's growth strategy for Europe was to move into the Spanish market. Read how a Spanish team was assembled within a tight timeframe, with the help of Quintiles’ global and local reach, high profile in the marketplace, depth of experience and expertise.

  • NHS Motivating Patients

    May 7, 2010
    In 2008, the NHS announced plans to offer free health checks for heart disease, stroke, diabetes and kidney disease. Learn why Quintiles was the right ally for the NHS to successfully launch this cardio risk assessment program.

  • Assessing the Business Impact of Comparative Effectiveness

    November 9, 2009
    The increasing use of Health Technology Assessments (HTA) is emerging as a policy issue that could have significant effects on every link in the product development chain.

Page 1 of 1 (8 results)

Subscribe to Email Based on Your Interests

Set preferences